SIFI merges into Faes Farma to become its ophthalmic franchise and expand international access to its portfolio and pipeline

The transaction will enable strong commercial synergies, thanks to Faes Farma's presence in complementary markets and recent acquisition of Laboratorios EdolIt enables funding further development of SIFI's portfolio, most notably Akantior in the USASIFI's existing infrastructure, including its Aci S. Antonio facilities, will further expand under the combined entity View original content:https://www.prnewswire.co.uk/news-releases/sifi-merges-into-faes-farma-to-become-its-ophthalmic-franchise-and-expand-international-access-to-its-portfolio-and-pipeline-302477967.html